STAT News · Scour

Opinion: STAT readers debate blue zones, open-access publishing fees, and more

Opinion: Why the space in ‘health care’ matters

STAT+: Up and down the ladder: The latest comings and goings

Opinion: Maternity deserts aren’t accidents. They’re the result of a design flaw

Tennessee pharmacies sell potent ivermectin, led by anti-vaccine doctor who’s taken ‘bucketloads’

Federal grant delays could jeopardize essential disability services, research

Opinion: STAT+: The real work for making dramatic gains against pancreatic cancer is just beginning

STAT+: CMS recalculates Medicare Advantage star ratings again, adding more volatility to program

STAT+: FDA advisory panel endorses Moderna mRNA flu vaccine that was subject of controversy

STAT+: Eli Lilly ends 340B drug discounts to some hospitals for failing to provide claims data

New hope in treating Huntington’s disease and a report card on RFK Jr.’s promises

Ebola cases increase almost 40% in a week as death toll passes 200

STAT+: Do wearables actually help people with cardiovascular disease?

STAT+: Cambrian’s experimental longevity drug mimics exercise

STAT+: Shingles vaccine may lower dementia risk, new study finds

STAT+: Pharmalittle: We’re reading about an FDA review of Moderna’s flu shot, J&J’s focus on cancer, and more

How many Americans can afford high-quality health care? A new poll finds the number has fallen

Six of the biggest health news stories today

STAT+: In pancreatic cancer, Patrick Soon-Shiong makes promises he has not kept

Super-potent synthetic opioids called nitazenes are spreading across the U.S.

Log in to enable infinite scrolling